Coastal Bridge Advisors’s AbbVie ABBV Stock Holding History

Coastal Bridge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.5M	Buy	61,434 +1,266	+2%	+$272K	0.96%	27
2026 Q1	$13.1M	Buy	60,168 +500	+0.8%	+$111K	0.92%	26
2025 Q4	$13.6M	Sell	59,668 -1,177	-2%	-$268K	1.02%	18
2025 Q3	$14.1M	Sell	60,845 -65	-0.1%	-$13.2K	1.07%	19
2025 Q2	$11.3M	Buy	60,910 +1,040	+2%	+$193K	0.93%	20
2025 Q1	$12.5M	Buy	+59,870	New	+$11.6M	1.14%	15
2024 Q4	–	Sell	-1,053	Closed	-$208K	–	164
2024 Q3	$208K	Buy	+1,053	New	+$197K	0.05%	154
2023 Q1	–	Sell	-1,353	Closed	-$219K	–	177
2022 Q4	$219K	Buy	+1,353	New	+$207K	0.06%	136

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Coastal Bridge Advisors's ABBV Position: Q2 2026 in Review

Coastal Bridge Advisors increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $272K and bringing the position to 61,434 shares worth $15.5M. The position accounts for 0.96% of the portfolio, ranked #27.

Coastal Bridge Advisors first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Coastal Bridge Advisors held 61,434 shares of AbbVie worth $15.5M as of Q2 2026.
Coastal Bridge Advisors bought 1,266 AbbVie shares in Q2 2026, an estimated $272K.
AbbVie made up 0.96% of Coastal Bridge Advisors's portfolio in Q2 2026, its #27 holding.
Coastal Bridge Advisors first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.